The expanding demand for precise immunological research and therapeutic design has spurred significant improvements in recombinant signal molecule production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently manufactured using diverse expression systems, including bacterial hosts, animal cell populations, and ba